BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 18512174)

  • 1. Tumour-like lesions in multiple sclerosis.
    Jamroz-Wiśniewska A; Janczarek M; Belniak E; Stelmasiak Z; Bartosik-Psujek H
    Neurol Neurochir Pol; 2008; 42(2):161-7. PubMed ID: 18512174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumefactive demyelinating lesion.
    Guilfoyle MR; Kirollos RW
    Neurology; 2007 Jun; 68(24):2155. PubMed ID: 17562840
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumefactive demyelinating lesions: A comprehensive review.
    Algahtani H; Shirah B; Alassiri A
    Mult Scler Relat Disord; 2017 May; 14():72-79. PubMed ID: 28619436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
    Kilic AK; Kurne AT; Oguz KK; Soylemezoglu F; Karabudak R
    Turk Neurosurg; 2013; 23(6):728-35. PubMed ID: 24310455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study.
    Altintas A; Petek B; Isik N; Terzi M; Bolukbasi F; Tavsanli M; Saip S; Boz C; Aydin T; Arici-Duz O; Ozer F; Siva A
    Mult Scler; 2012 Oct; 18(10):1448-53. PubMed ID: 22419670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm.
    Kiriyama T; Kataoka H; Taoka T; Tonomura Y; Terashima M; Morikawa M; Tanizawa E; Kawahara M; Furiya Y; Sugie K; Kichikawa K; Ueno S
    J Neuroimaging; 2011 Apr; 21(2):e69-77. PubMed ID: 20572907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumefactive Demyelinating Lesion Differentiated from a Brain Tumor Using a Combination of Magnetic Resonance Imaging and (11)C-methionine Positron Emission Tomography.
    Ninomiya S; Hara M; Morita A; Teramoto H; Momose M; Takahashi T; Kamei S
    Intern Med; 2015; 54(11):1411-4. PubMed ID: 26027998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumefactive demyelinating lesions.
    Dagher AP; Smirniotopoulos J
    Neuroradiology; 1996 Aug; 38(6):560-5. PubMed ID: 8880719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and magnetic resonance imaging (MRI) distinctions between tumefactive demyelination and brain tumors in children.
    Yiu EM; Laughlin S; Verhey LH; Banwell BL;
    J Child Neurol; 2014 May; 29(5):654-65. PubMed ID: 24092896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors of tumefactive demyelinating lesions and differential features for multiple sclerosis in etiology.
    Saridas F; Mesut G; Ceylan CY; Ozpar R; Ozsen M; Koc ER; Tolunay S; Hakyemez B; Turan OF
    Mult Scler Relat Disord; 2024 May; 85():105537. PubMed ID: 38460252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients.
    Kepes JJ
    Ann Neurol; 1993 Jan; 33(1):18-27. PubMed ID: 8494332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign course of tumour-like multiple sclerosis. Report of five cases and literature review.
    Turatti M; Gajofatto A; Bianchi MR; Ferrari S; Monaco S; Benedetti MD
    J Neurol Sci; 2013 Jan; 324(1-2):156-62. PubMed ID: 23151425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.
    Totaro R; Di Carmine C; Splendiani A; Torlone S; Patriarca L; Carrocci C; Sciamanna S; Marini C; Carolei A
    Neurol Sci; 2016 Jul; 37(7):1113-7. PubMed ID: 27083895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A challenging diagnosis of late-onset tumefactive multiple sclerosis associated to cervicodorsal syringomyelia: doubtful CT, MRI, and bioptic findings: Case report and literature review.
    Conforti R; Capasso R; Galasso R; Cirillo M; Taglialatela G; Galasso L
    Medicine (Baltimore); 2016 Sep; 95(36):e4585. PubMed ID: 27603348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis of pediatric multiple sclerosis initially presenting with tumefactive demyelinating lesion using ¹H-magnetic resonance spectroscopy].
    Kageyama T; Gotoh Y; Sano F; Katoh T; Nambu M; Okada T; Suenaga T
    Rinsho Shinkeigaku; 2011 Sep; 51(9):688-93. PubMed ID: 21946426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute tumefactive demyelinating lesions in a pediatric patient with known diagnosis of multiple sclerosis: review of the literature and treatment proposal.
    Dastgir J; DiMario FJ
    J Child Neurol; 2009 Apr; 24(4):431-7. PubMed ID: 19189932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging of multiple sclerosis simulating brain tumor.
    Kurihara N; Takahashi S; Furuta A; Higano S; Matsumoto K; Tobita M; Konno H; Sakamoto K
    Clin Imaging; 1996; 20(3):171-7. PubMed ID: 8877168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 52-year-old man with progressive left-sided weakness and white matter disease.
    Fleming JO; Keegan BM; Parisi JE
    Neurology; 2007 Aug; 69(6):600-6. PubMed ID: 17679680
    [No Abstract]   [Full Text] [Related]  

  • 19. [Aphasia and parietal syndrome as the presenting symptoms of a demyelinating disease with pseudotumoral lesions].
    Navarro S; Mondéjar-Marín B; Pedrosa-Guerrero A; Pérez-Molina I; Garrido-Robres JA; Alvarez-Tejerina A
    Rev Neurol; 2005 Nov 16-30; 41(10):601-3. PubMed ID: 16288423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monophasic, solitary tumefactive demyelinating lesion: neuroimaging features and neuropathological diagnosis.
    Tan HM; Chan LL; Chuah KL; Goh NS; Tang KK
    Br J Radiol; 2004 Feb; 77(914):153-6. PubMed ID: 15010391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.